The effects of alanine-substituted conantokin-G and ifenprodil on the human spermine-activated N-methyl-D-aspartate receptor

Neuroscience

Volumn 130, Issue 2, 2005, Pages 457-464

  Tsai, V W W ^a   Dodd, P R ^a   Lewis, R J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

cerebral cortex; excitotoxicity; glutamate receptors; human brain; polyamines

Indexed keywords

ALANINE; CONANTOKIN G; DIZOCILPINE; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SPERMINE;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOPSY; BINDING COMPETITION; BRAIN CORTEX; BRAIN MEMBRANE; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; HUMAN TISSUE; IC 50; MEMBRANE BINDING; PRIORITY JOURNAL;

EID: 12344311907     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.09.039     Document Type: Article

References (50)

1. D.J. Adams, P.F. Alewood, D.J. Craik, R. Drinkwater, R.J. Lewis Conotoxins and their potential pharmaceutical applications Drug Dev Res 46 1999 219 234
2. 3H]MK-801 binding to N-methyl-d-aspartate receptors solubilized from rat brain: effects of glycine site ligands, polyamines, ifenprodil, and desipramine J Neurochem 57 1991 39 45
3. T.A. Benke, O.T. Jones, G.L. Collingridge, K.J. Angelides N-methyl-d-aspartate receptors are clustered and immobilized on dendrites of living cortical neurons Proc Natl Acad Sci USA 90 1993 7819 7823
4. M. Benveniste, M.L. Mayer Multiple effects of spermine on N-methyl-d-aspartic acid receptor responses of rat cultured hippocampal neurones J Physiol 464 1993 131 163
5. J. Blahos 2nd, R.J. Wenthold Relationship between N-methyl-d-aspartate receptor NR1 splice variants and NR2 subunits J Biol Chem 271 1996 15669 15674
6. T. Blandl, M. Prorok, F.J. Castellino NMDA-receptor antagonist requirements in conantokin-G FEBS Lett 435 1998 257 262
7. C.J. Carter, K.G. Lloyd, B. Zivkovic, B. Scatton Ifenprodil and SL 82.0715 as cerebral antiischemic agents: III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-d-aspartate receptor complex J Pharmacol Exp Ther 253 1990 475 482
8. P. Chandler, M. Pennington, M.L. Maccecchini, N.T. Nashed, P. Skolnick Polyamine-like actions of peptides derived from conantokin-G, an N-methyl-d-aspartate (NMDA) antagonist J Biol Chem 268 1993 17173 17178
9. P.R. Dodd Excited to death: different ways to lose your neurones Biogerontology 3 2002 51 56
10. P.R. Dodd, J.A. Hardy, E.B. Baig, A.M. Kidd, E.D. Bird, W.E. Watson, G.A. Johnston Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain Neurochem Pathol 4 1986 177 198
11. S.D. Donevan, R.T. McCabe Conantokin G is an NR2B-selective competitive antagonist of N-methyl-d-aspartate receptors Mol Pharmacol 58 2000 614 623
12. G.M. Durand, M.V. Bennett, R.S. Zukin Splice variants of the N-methyl-d-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C Proc Natl Acad Sci USA 90 1993 6731 6735
13. M.J. Gallagher, H. Huang, D.B. Pritchett, D.R. Lynch Interactions between ifenprodil and the NR2B subunit of the N-methyl-d-aspartate receptor J Biol Chem 271 1996 9603 9611
14. (3)H]ifenprodil binding to recombinant human NR1a/NR2B receptors compared with native receptors in rodent brain membranes J Neurochem 75 2000 2455 2463
15. J.A. Haack, T.N. Parks, B.M. Olivera Conantokin-G antagonism of the NMDA receptor subtype expressed in cultured cerebellar granule cells Neurosci Lett 163 1993 63 66
16. J.A. Haack, J. Rivier, T.N. Parks, E.E. Mena, L.J. Cruz, B.M. Olivera Conantokin-T: a gamma-carboxyglutamate containing peptide with N-methyl-d-aspartate antagonist activity J Biol Chem 265 1990 6025 6029
17. L.G. Hammerland, B.M. Olivera, D. Yoshikami Conantokin-G selectively inhibits N-methyl-d-aspartate-induced currents in Xenopus oocytes injected with mouse brain mRNA Eur J Pharmacol 226 1992 239 244
18. M. Hollmann, J. Boulter, C. Maron, L. Beasley, J. Sullivan, G. Pecht, S. Heinemann Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor Neuron 10 1993 943 954
19. M.R. Hynd, H.L. Scott, P.R. Dodd Glutamate (NMDA) receptor NR1 subunit mRNA expression in Alzheimer's disease J Neurochem 78 2001 175 182
20. T.D. Johnson Modulation of channel function by polyamines Trends Pharmacol Sci 17 1996 22 27
21. T. Kutsuwada, N. Kashiwabuchi, H. Mori, K. Sakimura, E. Kushiya, K. Araki, H. Meguro, H. Masaki, T. Kumanishi, M. Arakawa Molecular diversity of the NMDA receptor channel Nature 358 1992 36 41
22. P.D. Leeson, L.L. Iversen The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential J Med Chem 37 1994 4053 4067
23. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
24. J.C. Marvizon, M. Baudry Allosteric interactions and modulator requirement for NMDA receptor function Eur J Pharmacol 269 1994 165 175
25. J.W. McDonald, M.V. Johnston Physiological and pathophysiological roles of excitatory amino acids during central nervous system development Brain Res Brain Res Rev 15 1990 41 70
26. G.A. McPherson A practical computer-based approach to the analysis of radioligand binding experiments Comput Programs Biomed 17 1983 107 113
27. E.E. Mena, M.F. Gullak, M.J. Pagnozzi, K.E. Richter, J. Rivier, L.J. Cruz, B.M. Olivera Conantokin-G: a novel peptide antagonist to the N-methyl-d-aspartic acid (NMDA) receptor Neurosci Lett 118 1990 241 244
28. K. Moriyoshi, M. Masu, T. Ishii, R. Shigemoto, N. Mizuno, S. Nakanishi Molecular cloning and characterization of the rat NMDA receptor Nature 354 1991 31 37
29. L.D. Morrison, S.J. Kish Brain polyamine levels are altered in Alzheimer's disease Neurosci Lett 197 1995 5 8
30. M. Mortensen, I. Matsumoto, S. Niwa, P.R. Dodd The modulatory effect of spermine on the glutamate-NMDA receptor is regionally variable in normal human adult cerebral cortex Pharmacol Toxicol 84 1999 135 142
31. P.J. Munson, D. Rodbard Ligand: a versatile computerized approach for characterization of ligand-binding systems Anal Biochem 107 1980 220 239
32. J.W. Olney New mechanisms of excitatory transmitter neurotoxicity J Neural Transm Suppl 43 1994 47 51
33. F. Perin-Dureau, J. Rachline, J. Neyton, P. Paoletti Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors J Neurosci 22 2002 5955 5965
34. L. Ragnarsson, M. Mortensen, P.R. Dodd, R.J. Lewis Spermine modulation of the glutamate(NMDA) receptor is differentially responsive to conantokins in normal and Alzheimer's disease human cerebral cortex J Neurochem 81 2002 765 779
35. I.J. Reynolds Arcaine uncovers dual interactions of polyamines with the N-methyl-d-aspartate receptor J Pharmacol Exp Ther 255 1990 1001 1007
36. 2+ and polyamines independently of the arcaine-sensitive polyamine site J Neurochem 62 1994 54 62
37. I.J. Reynolds, R.J. Miller Ifenprodil is a novel type of N-methyl-d-aspartate receptor antagonist: interaction with polyamines Mol Pharmacol 36 1989 758 765
38. M. Rigby, B. Le Bourdelles, R.P. Heavens, S. Kelly, D. Smith, A. Butler, R. Hammans, R. Hills, J.H. Xuereb, R.G. Hill, P.J. Whiting, D.J. Sirinathsinghji The messenger RNAs for the N-methyl-d-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain Neuroscience 73 1996 429 447
39. D.M. Rock, R.L. Macdonald Polyamine regulation of N-methyl-d-aspartate receptor channels Annu Rev Pharmacol Toxicol 35 1995 463 482
40. 3H]N-(1-[thienyl]cyclohexyl) piperidine binding to the N-methyl-d-aspartate receptor ionophore complex Mol Pharmacol 37 1990 572 577
41. 125I]MK-801 binding to recombinant N-methyl-d-aspartate receptors J Pharmacol Exp Ther 289 1999 1041 1047
42. N. Skjaerbaek, K.J. Nielsen, R.J. Lewis, P. Alewood, D.J. Craik Determination of the solution structures of conantokin-G and conantokin-T by CD and NMR spectroscopy J Biol Chem 272 1997 2291 2299
43. P. Skolnick, K. Boje, R. Miller, M. Pennington, M.L. Maccecchini Noncompetitive inhibition of N-methyl-d-aspartate by conantokin-G: evidence for an allosteric interaction at polyamine sites J Neurochem 59 1992 1516 1521
44. 3H]MK-801 binding to the NMDA receptor complex in human cortical membranes Eur J Pharmacol 189 1990 195 200
45. K. Williams Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors Mol Pharmacol 44 1993 851 859
46. K. Williams Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-d-aspartate receptors Mol Pharmacol 46 1994 161 168
47. 3H]MK-801 to the N-methyl-d-aspartate receptor: pharmacological evidence for the existence of a polyamine recognition site Mol Pharmacol 36 1989 575 581
48. M. Yamazaki, H. Mori, K. Araki, K.J. Mori, M. Mishina Cloning, expression and modulation of a mouse NMDA receptor subunit FEBS Lett 300 1992 39 45
49. Y. Yoneda, K. Ogita Neurochemical aspects of the N-methyl-d-aspartate receptor complex Neurosci Res 10 1991 1 33
50. L.M. Zhou, G.I. Szendrei, L.H. Fossom, M.L. Maccecchini, P. Skolnick, L. Otvos Jr Synthetic analogues of conantokin-G: NMDA antagonists acting through a novel polyamine-coupled site J Neurochem 66 1996 620 628